PLC Fits Modular Design Approach For Inline Printer

Tailored for printing pharmaceutical packaging materials, Hapa’s Web 4.0 meets internal control requirements while delivering key customer benefits.

The Web 4.0 is an Industry 4.0-ready UV digital printing system for web-fed foils that prints up to 60 meters/min, with a 720 x 720 dpi resolution.
The Web 4.0 is an Industry 4.0-ready UV digital printing system for web-fed foils that prints up to 60 meters/min, with a 720 x 720 dpi resolution.

Hapa’s Web 4.0 employs PLC and machine control architecture designed to boost efficiency in a digital workflow.

Switzerland-based Hapa is a member of the Italy-based Coesia group and is known for its direct printing equipment for printing pharmaceutical materials such as blister lidding foils, blisters, labels, cartons, tubes, and closures. That includes Web 4.0, which was officially introduced at interpack 2017.

“Hapa historically used its own proprietary PLC and controls because there was no market alternative that provided machine synchronization capability to the levels required by Hapa’s applications,” explains Product Manager James Freer. “However, developments for industrial PLCs now not only offer the desired level of machine control and accuracy, but also the benefits of mass production and reliability.”

With those benefits in mind, Hapa turned to B&R Industrial Automation. B&R gave Hapa a platform around which it built a print engine and machine control architecture that was generic and modular, which is now referred to as the Hapa Print Services architecture.

Researched List: Blister Machines for Life Sciences
Need a blister machine for life sciences packaging? Our curated list features companies serving pharmaceutical, medical device, nutraceutical, and cosmetic industries. Download to access company names, locations, machine specifications, descriptions, and more.
Download Now
Researched List: Blister Machines for Life Sciences
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?